ENSPRYNG (satralizumab-mwge) is used to treat neuromyelitis optica spectrum disorder (NMOSD) in adults who are AQP4-IgG(+).

HEAR FROM OTHERS LIKE YOU

Watch real people with NMOSD describe their experiences

A SUBCUTANEOUS INJECTION YOU CAN TAKE AT HOME

Learn how to take ENSPRYNG after proper guidance

FINANCIAL ASSISTANCE, RESOURCES, AND MORE

Get valuable information, resources, and community support